Reviva Pharmaceuticals I... (RVPHW)

AI Score

Unlock

0.06

0.01 (12.15%)

At close: Apr 22, 2025, 3:59 PM

Reviva Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Aug 31, 2020	May 31, 2020	Feb 29, 2020	Nov 30, 2019	Aug 31, 2019	May 31, 2019	Feb 28, 2019	Nov 30, 2018	Aug 31, 2018
Cash & Equivalents	13.48M	5.56M	6.18M	11.97M	23.37M	4.97M	11.15M	11.26M	18.52M	23.19M	19.42M	23.42M	29.69M	33.49M	35.8M	5.64M	8.76M	15.54K	n/a	169.53K	134.31K	211.24K	n/a	n/a	n/a	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	34.22M	n/a	n/a	n/a	65.65M	n/a	64.88M	64.54M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	819.72K	819.72K	819.72K	n/a	n/a	n/a	n/a	n/a	403.82M	n/a	n/a	n/a	1.72M	n/a	n/a	1.82K	1.82K	34.44M	n/a	26.82K	66.32M	66.02M	n/a	-118.64K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	666.43K	n/a	525.83K	743.38K	332.93K	414.74K	690.44K	1.65M	403.82K	849.02K	1.22M	1.85M	1.72M	402.32K	733.93K	1.01M	7.62K	22.57K	n/a	n/a	15.66K	38.57K	n/a	n/a	n/a	n/a
Total Current Assets	14.68M	6.81M	7.23M	13.5M	23.7M	5.39M	11.84M	12.9M	18.92M	24.04M	20.64M	25.27M	31.4M	33.89M	36.53M	6.66M	8.76M	38.11K	34.22M	169.53K	149.96K	249.81K	65.65M	118.64K	64.88M	64.54M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	430.00	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	819.72K	819.72K	819.72K	n/a	n/a	n/a	n/a	n/a	403.82M	n/a	n/a	n/a	1.72M	n/a	n/a	1.82K	1.82K	34.44M	n/a	27.25K	66.32M	66.02M	n/a	-118.64K	n/a	n/a
Total Assets	15.5M	7.63M	8.05M	13.5M	23.7M	5.39M	11.84M	12.9M	18.92M	24.04M	20.64M	25.27M	31.4M	33.89M	36.53M	6.66M	8.76M	34.48M	34.22M	196.78K	66.47M	66.27M	65.65M	n/a	64.88M	64.54M
Account Payables	6.28M	8.78M	4.69M	5.72M	3.85M	5.28M	2.65M	2.86M	3.52M	2.35M	2.55M	1.43M	509.58K	420.78K	358.26K	471.3K	1.01M	n/a	n/a	314.54K	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	458.15K	83K	207.5K	332K	n/a	222.5K	222.5K	667.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	635.59K	428.8K	445.37K	377.37K	400.49K	7.53M	6.34M	3.03M	2.52M	1.23M	1.92M	2.2M	1.84M	552.92K	804.49K	630.04K	324.7K	736.44K	n/a	100.74K	100.1K	33.93K	n/a	n/a	n/a	n/a
Total Current Liabilities	14.6M	17.53M	13.94M	14.49M	17.18M	13.03M	9.21M	6.56M	6.04M	3.58M	4.48M	3.62M	2.34M	973.7K	1.16M	1.1M	1.33M	736.44K	n/a	7.76M	100.1K	33.93K	n/a	n/a	n/a	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	89.01K	77.88K	150.21K	350.48K	806.65K	n/a	1.01M	556.31K	567.44K	105.7K	105.7K	283.72K	372.73K	650.89K	851.16K	1.04M	4.19M	3.64M	n/a	n/a	2.21M	2.21M	n/a	5.96M	n/a	n/a
Total Long-Term Liabilities	89.01K	77.88K	150.21K	350.48K	806.65K	873.41K	1.01M	556.31K	567.44K	105.7K	105.7K	283.72K	372.73K	650.89K	851.16K	1.04M	4.19M	3.64M	n/a	n/a	2.21M	2.21M	n/a	5.96M	n/a	n/a
Total Liabilities	14.69M	17.61M	14.09M	14.84M	17.98M	13.91M	10.22M	7.12M	6.61M	3.68M	4.58M	3.91M	2.72M	1.62M	2.01M	2.14M	1.33M	4.38M	n/a	7.76M	2.31M	2.25M	n/a	5.96M	n/a	n/a
Total Debt	458.15K	83K	207.5K	332K	n/a	222.5K	222.5K	667.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4M	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	4.66K	3.34K	2.98K	2.79K	2.79K	2.27K	2.27K	2.04K	2.04K	2.04K	1.51K	1.51K	1.44K	1.34K	1.34K	923.00	923.00	29.58M	n/a	618.00	62.84M	62.84M	n/a	n/a	n/a	n/a
Retained Earnings	-164.27M	-158.01M	-149.65M	-141.79M	-134.35M	-120.71M	-110.22M	-97.77M	-91.17M	-83.05M	-79.54M	-74.2M	-66.83M	-63.15M	-60.87M	-59.26M	-58.31M	520.24K	n/a	-55.28M	1.32M	1.19M	n/a	n/a	n/a	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	n/a	-35.03M	n/a	n/a
Shareholders Equity	812.57K	-9.98M	-6.04M	-1.35M	5.72M	-8.52M	1.62M	5.78M	12.32M	20.36M	16.06M	21.36M	28.69M	32.27M	34.52M	4.52M	7.43M	5M	n/a	57.76M	5M	5M	n/a	-5.96M	n/a	n/a
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	34.22M	n/a	n/a	n/a	65.65M	n/a	64.88M	64.54M